Literature DB >> 1424182

The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.

G Philippou1, D A Koutras, G Piperingos, A Souvatzoglou, S D Moulopoulos.   

Abstract

OBJECTIVE: To clarify the duration and the extent of the antithyroid effect of iodides in hyperthyroidism, and to investigate whether iodides have an additional peripheral effect on the metabolism of thyroid hormones, as has been reported for some organic iodine compounds.
DESIGN: The effect on the peripheral thyroid hormone levels of 150 mg of potassium iodide daily (equivalent to 114 mg of iodide) for 3-7 weeks was compared in 21 hyperthyroid patients and 12 healthy controls. A possible effect of iodide on the peripheral metabolism of thyroid hormones was investigated by assessing the serum levels of thyroid hormone in 12 hypothyroid patients on thyroxine replacement for 2 weeks. PATIENTS: There were 21 thyrotoxic patients, 12 healthy hospital controls, and 12 patients with complete or near-complete hypothyroidism, on thyroxine replacement. MEASUREMENTS: The following were measured before and at weekly intervals after iodide administration: (1) pulse rate, (2) serum T4, (3) serum T3, (4) serum TSH, (5) serum thyroxine-binding capacity (TBC), (6) serum rT3, (7) serum thyroxine-binding globulin (TBG), (8) the free-T4 Index, calculated as T4/TBC.
RESULTS: In the hyperthyroid patients serum T4, T3 and rT3 decreased, whereas serum thyroxine-binding globulin and thyroxine binding capacity increased. Serum T3, however, did not become completely normal in all cases. After 21 days, serum T4 and T3 started increasing again in some cases, but other patients remained euthyroid even after 6 weeks. In the normal controls there was a small but significant and consistent decrease in serum T4, T3 and rT3 and an increase in serum TSH. Finally, in the T4-treated hypothyroid patients there was no consistent change, except for an increase of serum T4 at 1 and 14 days and a decrease of serum TSH the first day.
CONCLUSION: Iodides in hyperthyroidism have a variable and unpredictable intensity and duration of antithyroid effect. Their antithyroid effect is smaller in normal controls. They have no important effect on the peripheral metabolism of thyroid hormones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424182     DOI: 10.1111/j.1365-2265.1992.tb02267.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Thyroid dysfunction following a kelp-containing marketed diet.

Authors:  Tiziana Di Matola; Pio Zeppa; Maurizio Gasperi; Mario Vitale
Journal:  BMJ Case Rep       Date:  2014-10-29

2.  Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.

Authors:  Toyoyoshi Uchida; Hiromasa Goto; Takatoshi Kasai; Koji Komiya; Kageumi Takeno; Hiroko Abe; Nayumi Shigihara; Junko Sato; Akira Honda; Tomoya Mita; Akio Kanazawa; Yoshio Fujitani; Hirotaka Watada
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

3.  Metallothionein-I/II Knockout Mice Aggravate Mitochondrial Superoxide Production and Peroxiredoxin 3 Expression in Thyroid after Excessive Iodide Exposure.

Authors:  Na Zhang; Lingyan Wang; Qi Duan; Laixiang Lin; Mohamed Ahmed; Tingting Wang; Xiaomei Yao
Journal:  Oxid Med Cell Longev       Date:  2015-05-25       Impact factor: 6.543

4.  Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocr Connect       Date:  2017-03-21       Impact factor: 3.335

Review 5.  Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future.

Authors:  Nattakarn Suwansaksri; Lukana Preechasuk; Tada Kunavisarut
Journal:  Int J Endocrinol       Date:  2018-04-22       Impact factor: 3.257

Review 6.  Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Authors:  Li Jing; Qiang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

Review 7.  Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocrine       Date:  2017-10-26       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.